On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages 12 to 17
On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages 12 to 17
Moderna has announced its two-dose COVID-19 vaccine is safe and effective in adolescents. KDKA's Dr. Maria Simbra has more.
A vaccine advisory committee to the Centers for Disease Control and Prevention is set to meet Wednesday to make recommendations..